SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CHD'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EE2_A_CHDA1150_0 (ALCOHOLDEHYDROGENASE) |
1ee2 | ALCOHOLDEHYDROGENASE (Equuscaballus) | 11 / 11 | CYH A 46SER A 48LEU A 57HIS A 67LEU A 110SER A 116MET A 117LEU A 140CYH A 173VAL A 293ILE A 317 | ZN A1300 ( 2.3A)CHD A1150 ( 2.5A)CHD A1150 (-4.5A) ZN A1300 ( 3.2A)NoneCHD A1150 (-2.8A)CHD A1150 (-4.2A)None ZN A1300 (-2.2A)NAD A1100 ( 4.0A)CHD A1150 ( 4.3A) | 0.02A | 1ee2A-1ee2A:71.0 | 1ee2A-1ee2A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EE2_B_CHDB1250_1 (ALCOHOLDEHYDROGENASE) |
1ee2 | ALCOHOLDEHYDROGENASE (Equuscaballus) | 11 / 11 | CYH A 46SER A 48LEU A 57HIS A 67LEU A 110SER A 116MET A 117LEU A 140CYH A 173VAL A 293ILE A 317 | ZN A1300 ( 2.3A)CHD A1150 ( 2.5A)CHD A1150 (-4.5A) ZN A1300 ( 3.2A)NoneCHD A1150 (-2.8A)CHD A1150 (-4.2A)None ZN A1300 (-2.2A)NAD A1100 ( 4.0A)CHD A1150 ( 4.3A) | 0.12A | 1ee2B-1ee2A:68.6 | 1ee2B-1ee2A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HRK_A_CHDA1501_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99ILE A 119HIS A 263LEU A 265PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneCHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.36A | 1hrkA-3aqiA:61.1 | 1hrkA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HRK_A_CHDA1502_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 8 | MET A 99ARG A 114LEU A 115PRO A 266VAL A 305GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.34A | 1hrkA-3aqiA:61.1 | 1hrkA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HRK_A_CHDA1503_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101PRO A 102LEU A 107 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A) | 0.38A | 1hrkA-3aqiA:61.1 | 1hrkA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HRK_B_CHDB2501_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99ILE A 119HIS A 263PRO A 266VAL A 269ARG A 272VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneCHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneFES A 501 (-4.1A)CHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.54A | 1hrkB-3aqiA:60.9 | 1hrkB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HRK_B_CHDB2502_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 8 | MET A 99ARG A 114LEU A 115PRO A 266VAL A 305GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.37A | 1hrkB-3aqiA:60.9 | 1hrkB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1HRK_B_CHDB2503_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 4 | LEU A 101PRO A 102LEU A 107ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.46A | 1hrkB-3aqiA:60.9 | 1hrkB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TW4_A_CHDA130_0 (FATTY ACID-BINDINGPROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 5 / 12 | LEU A 18ALA A 31ASP A 74HIS A 98ARG A 120 | CHD A 130 ( 4.7A)CHD A 130 ( 3.8A)GOL A 145 ( 2.8A)IPA A 140 (-3.7A)CHD A 130 (-3.4A) | 0.69A | 1tw4A-2qo4A:21.6 | 1tw4A-2qo4A:69.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TW4_B_CHDB1130_0 (FATTY ACID-BINDINGPROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 5 / 12 | TYR A 14LEU A 18MET A 73HIS A 98ARG A 120 | NoneCHD A 130 ( 4.7A)NoneIPA A 140 (-3.7A)CHD A 130 (-3.4A) | 0.98A | 1tw4B-2qo4A:21.5 | 1tw4B-2qo4A:69.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TW4_B_CHDB1130_0 (FATTY ACID-BINDINGPROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 5 / 12 | TYR A 14LEU A 18THR A 53MET A 73ARG A 120 | NoneCHD A 130 ( 4.7A)CHD A 130 ( 4.1A)NoneCHD A 130 (-3.4A) | 0.91A | 1tw4B-2qo4A:21.5 | 1tw4B-2qo4A:69.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V54_C_CHDC3271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE IIICYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEART) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 8 | ARG C 156LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.31A | 1v54C-5iy5C:37.31v54J-5iy5C:undetectable | 1v54C-5iy5C:100.001v54J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V54_C_CHDC3271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE IIICYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEART) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 8 | ARG C 156LYS C 157LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.22A | 1v54C-5iy5C:37.31v54J-5iy5C:undetectable | 1v54C-5iy5C:100.001v54J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V54_P_CHDP4271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE IIICYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEART) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 7 / 8 | ARG C 156LYS C 157LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.52A | 1v54P-5iy5C:37.41v54W-5iy5C:undetectable | 1v54P-5iy5C:100.001v54W-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V55_C_CHDC3271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE IIICYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEART) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.46A | 1v55C-5iy5C:37.31v55J-5iy5C:undetectable | 1v55C-5iy5C:100.001v55J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V55_C_CHDC3271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE IIICYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEART) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.28A | 1v55C-5iy5C:37.31v55J-5iy5C:undetectable | 1v55C-5iy5C:100.001v55J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DYR_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 8 | ARG C 156LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.32A | 2dyrC-5iy5C:37.42dyrJ-5iy5C:undetectable | 2dyrC-5iy5C:100.002dyrJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DYR_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 8 | ARG C 156LYS C 157LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.25A | 2dyrC-5iy5C:37.42dyrJ-5iy5C:undetectable | 2dyrC-5iy5C:100.002dyrJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DYR_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 7 / 8 | ARG C 156LYS C 157LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.51A | 2dyrP-5iy5C:37.32dyrW-5iy5C:undetectable | 2dyrP-5iy5C:100.002dyrW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DYS_P_CHDP310_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.42A | 2dysP-5iy5C:37.12dysW-5iy5C:undetectable | 2dysP-5iy5C:100.002dysW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DYS_P_CHDP310_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.23A | 2dysP-5iy5C:37.12dysW-5iy5C:undetectable | 2dysP-5iy5C:100.002dysW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIJ_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.38A | 2eijC-5iy5C:37.42eijJ-5iy5C:undetectable | 2eijC-5iy5C:100.002eijJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIJ_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.25A | 2eijC-5iy5C:37.42eijJ-5iy5C:undetectable | 2eijC-5iy5C:100.002eijJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIK_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 7 | ARG C 156LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.44A | 2eikC-5iy5C:37.42eikJ-5iy5C:undetectable | 2eikC-5iy5C:100.002eikJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIK_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 7 / 8 | ARG C 156LYS C 157LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.52A | 2eikP-5iy5C:37.32eikW-5iy5C:undetectable | 2eikP-5iy5C:100.002eikW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIL_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 8 | ARG C 156LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.41A | 2eilC-5iy5C:37.32eilJ-5iy5C:undetectable | 2eilC-5iy5C:100.002eilJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIL_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 8 | ARG C 156LYS C 157LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.27A | 2eilC-5iy5C:37.32eilJ-5iy5C:undetectable | 2eilC-5iy5C:100.002eilJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIM_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.51A | 2eimC-5iy5C:36.92eimJ-5iy5C:undetectable | 2eimC-5iy5C:100.002eimJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIM_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.37A | 2eimC-5iy5C:36.92eimJ-5iy5C:undetectable | 2eimC-5iy5C:100.002eimJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIM_W_CHDW1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.28A | 2eimP-5iy5C:36.82eimW-5iy5C:undetectable | 2eimP-5iy5C:100.002eimW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIN_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.48A | 2einC-5iy5C:36.72einJ-5iy5C:undetectable | 2einC-5iy5C:100.002einJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIN_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.27A | 2einC-5iy5C:36.72einJ-5iy5C:undetectable | 2einC-5iy5C:100.002einJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EIN_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156LEU C 160GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.46A | 2einP-5iy5C:36.72einW-5iy5C:undetectable | 2einP-5iy5C:100.002einW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FT9_A_CHDA130_0 (FATTY ACID-BINDINGPROTEIN 2, LIVER) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 7 / 12 | PHE A 17ASN A 60PHE A 62ILE A 70VAL A 82HIS A 98LEU A 111 | NoneIPA A 141 ( 4.7A)IPA A 142 ( 4.4A)IPA A 141 ( 4.5A)NoneIPA A 140 (-3.7A)CHD A 130 ( 4.9A) | 1.05A | 2ft9A-2qo4A:20.7 | 2ft9A-2qo4A:69.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FT9_A_CHDA131_0 (FATTY ACID-BINDINGPROTEIN 2, LIVER) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 5 / 11 | TYR A 14LEU A 18THR A 53PRO A 54LEU A 111 | NoneCHD A 130 ( 4.7A)CHD A 130 ( 4.1A)NoneCHD A 130 ( 4.9A) | 0.95A | 2ft9A-2qo4A:20.7 | 2ft9A-2qo4A:69.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_A_CHDA701_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 12 | ILE A 342SER A 195PRO A 266VAL A 269TRP A 310 | NoneNoneCHD A 2 ( 4.5A)NoneCHD A 2 (-4.7A) | 1.02A | 2hrcA-3aqiA:60.0 | 2hrcA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_A_CHDA701_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98ILE A 119SER A 197HIS A 263LEU A 265PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)NoneCHD A 1 (-3.0A)CHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.56A | 2hrcA-3aqiA:60.0 | 2hrcA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_A_CHDA701_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 12 | SER A 195HIS A 263LEU A 265PRO A 266VAL A 269TRP A 310 | NoneCHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 2 (-4.7A) | 1.14A | 2hrcA-3aqiA:60.0 | 2hrcA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_A_CHDA702_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 7 / 7 | MET A 99ARG A 114LEU A 115PRO A 266VAL A 305MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)NoneCHD A 2 (-4.7A) | 0.26A | 2hrcA-3aqiA:60.0 | 2hrcA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_A_CHDA702_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 7 | MET A 99LEU A 89PRO A 266TRP A 310 | CHD A 2 (-4.0A)NoneCHD A 2 ( 4.5A)CHD A 2 (-4.7A) | 1.22A | 2hrcA-3aqiA:60.0 | 2hrcA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_A_CHDA703_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 4 | LEU A 101PRO A 102LEU A 107ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.23A | 2hrcA-3aqiA:60.0 | 2hrcA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_B_CHDB1603_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 5 | MET A 99ARG A 114LEU A 115PRO A 266MET A 308 | CHD A 2 (-4.0A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)None | 0.47A | 2hrcB-3aqiA:60.7 | 2hrcB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_B_CHDB1604_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 4 | LEU A 101PRO A 102LEU A 107ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.48A | 2hrcB-3aqiA:60.7 | 2hrcB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HRC_B_CHDB1605_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99ILE A 119HIS A 263LEU A 265PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneCHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.42A | 2hrcB-3aqiA:60.7 | 2hrcB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2JN3_A_JN3A130_1 (FATTY ACID-BINDINGPROTEIN, LIVER) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 6 / 12 | TYR A 14LEU A 18ALA A 31THR A 53ASP A 74HIS A 98 | NoneCHD A 130 ( 4.7A)CHD A 130 ( 3.8A)CHD A 130 ( 4.1A)GOL A 145 ( 2.8A)IPA A 140 (-3.7A) | 0.87A | 2jn3A-2qo4A:21.0 | 2jn3A-2qo4A:69.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2JN3_A_JN3A130_2 (FATTY ACID-BINDINGPROTEIN, LIVER) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 5 / 7 | PHE A 17LEU A 23PRO A 36GLU A 109ARG A 120 | NoneCHD A 130 ( 4.6A)NoneNoneCHD A 130 (-3.4A) | 0.72A | 2jn3A-2qo4A:21.0 | 2jn3A-2qo4A:69.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PNJ_A_CHDA501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 12 | LEU A 115ILE A 119HIS A 263LEU A 265PRO A 266VAL A 269 | CHD A 2 ( 4.8A)NoneCHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)None | 1.37A | 2pnjA-3aqiA:59.5 | 2pnjA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PNJ_A_CHDA501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 89LEU A 92PHE A 93LEU A 98MET A 99ILE A 119HIS A 263LEU A 265PRO A 266VAL A 269VAL A 305 | CHD A 1 ( 3.8A)NoneCHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneCHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A) | 0.35A | 2pnjA-3aqiA:59.5 | 2pnjA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PNJ_A_CHDA502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 5 | MET A 99PRO A 266VAL A 305MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)NoneCHD A 2 (-4.7A) | 0.14A | 2pnjA-3aqiA:59.5 | 2pnjA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PNJ_B_CHDB501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 12 | ILE A 342SER A 195PRO A 266VAL A 269TRP A 310 | NoneNoneCHD A 2 ( 4.5A)NoneCHD A 2 (-4.7A) | 0.99A | 2pnjB-3aqiA:59.7 | 2pnjB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PNJ_B_CHDB501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99ILE A 119SER A 197HIS A 263PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneCHD A 1 (-3.0A)CHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.44A | 2pnjB-3aqiA:59.7 | 2pnjB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PNJ_B_CHDB501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 12 | SER A 195HIS A 263PRO A 266VAL A 269TRP A 310 | NoneCHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneCHD A 2 (-4.7A) | 1.14A | 2pnjB-3aqiA:59.7 | 2pnjB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PNJ_B_CHDB502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 7 / 7 | MET A 99ILE A 111ARG A 114PRO A 266GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.34A | 2pnjB-3aqiA:59.7 | 2pnjB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PNJ_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 4 | LEU A 101PRO A 102LEU A 107ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.37A | 2pnjB-3aqiA:59.7 | 2pnjB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_A_CHDA501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 12 | ILE A 342SER A 195PRO A 266VAL A 269TRP A 310 | NoneNoneCHD A 2 ( 4.5A)NoneCHD A 2 (-4.7A) | 1.03A | 2po5A-3aqiA:60.6 | 2po5A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_A_CHDA501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99ILE A 119SER A 197LEU A 265PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneCHD A 1 (-3.0A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.63A | 2po5A-3aqiA:60.6 | 2po5A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_A_CHDA501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 12 | SER A 195LEU A 265PRO A 266VAL A 269TRP A 310 | NoneNoneCHD A 2 ( 4.5A)NoneCHD A 2 (-4.7A) | 1.16A | 2po5A-3aqiA:60.6 | 2po5A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_A_CHDA502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 8 | MET A 99LEU A 101ARG A 114LEU A 115PRO A 266VAL A 305GLY A 306MET A 308 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)None | 0.51A | 2po5A-3aqiA:60.6 | 2po5A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_B_CHDB501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 11 / 11 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99SER A 197LEU A 265PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)CHD A 1 (-3.0A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.69A | 2po5B-3aqiA:60.3 | 2po5B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_B_CHDB501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 11 | SER A 195LEU A 265PRO A 266VAL A 269TRP A 310 | NoneNoneCHD A 2 ( 4.5A)NoneCHD A 2 (-4.7A) | 1.17A | 2po5B-3aqiA:60.3 | 2po5B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_B_CHDB502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 8 | MET A 99LEU A 101ARG A 114LEU A 115PRO A 266VAL A 305GLY A 306MET A 308 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)None | 0.53A | 2po5B-3aqiA:60.3 | 2po5B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_B_CHDB502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 8 | MET A 99LEU A 101LEU A 89PRO A 266 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)NoneCHD A 2 ( 4.5A) | 0.88A | 2po5B-3aqiA:60.3 | 2po5B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO5_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101PRO A 102LEU A 107 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A) | 0.25A | 2po5B-3aqiA:37.1 | 2po5B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO7_A_CHDA501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98ILE A 119SER A 195HIS A 263LEU A 265PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)NoneNoneCHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.45A | 2po7A-3aqiA:60.4 | 2po7A-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO7_A_CHDA502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 9 / 9 | MET A 99LEU A 101ARG A 114LEU A 115PRO A 266VAL A 305GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.40A | 2po7A-3aqiA:60.4 | 2po7A-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO7_A_CHDA502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 9 | MET A 99LEU A 101LEU A 89PRO A 266TRP A 310 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)NoneCHD A 2 ( 4.5A)CHD A 2 (-4.7A) | 1.08A | 2po7A-3aqiA:60.4 | 2po7A-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO7_B_CHDB501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99ILE A 119SER A 195HIS A 263LEU A 265PRO A 266VAL A 269TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneNoneCHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 2 (-4.7A) | 0.57A | 2po7B-3aqiA:60.0 | 2po7B-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO7_B_CHDB502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 9 | LEU A 92PRO A 266VAL A 305GLY A 306TRP A 310 | CHD A 1 (-4.8A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)CHD A 2 (-4.7A) | 1.32A | 2po7B-3aqiA:60.0 | 2po7B-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO7_B_CHDB502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 9 / 9 | MET A 99LEU A 101ARG A 114LEU A 115PRO A 266VAL A 305GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.45A | 2po7B-3aqiA:60.0 | 2po7B-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PO7_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101PRO A 102LEU A 107 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A) | 0.20A | 2po7B-3aqiA:60.0 | 2po7B-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD2_A_CHDA2_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 8 | MET A 99LEU A 101PRO A 266SER A 268VAL A 305MET A 308 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)None | 0.86A | 2qd2A-3aqiA:54.3 | 2qd2A-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD2_B_CHDB1_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 10 | MET A 99LEU A 101PRO A 266SER A 268VAL A 305GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.78A | 2qd2B-3aqiA:53.8 | 2qd2B-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD3_A_CHDA501_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 11 | LEU A 89LEU A 92LEU A 98ILE A 119THR A 198HIS A 263VAL A 305TRP A 310 | NoneCHD A 1 (-4.8A)CHD A 1 (-4.3A)NoneNoneCHD A 1 (-4.3A)CHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.67A | 2qd3A-3aqiA:59.6 | 2qd3A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD3_A_CHDA502_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 7 / 8 | MET A 99PRO A 266SER A 268VAL A 305GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.36A | 2qd3A-3aqiA:59.6 | 2qd3A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD3_B_CHDB504_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 6 | MET A 99ILE A 111PRO A 266SER A 268MET A 308 | CHD A 2 (-4.0A)CHD A 2 ( 4.7A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)None | 0.28A | 2qd3B-3aqiA:60.0 | 2qd3B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD4_A_CHDA801_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 11 / 12 | LEU A 92PHE A 93LEU A 98GLN A 122SER A 197HIS A 263LEU A 265PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 1 ( 4.1A)CHD A 1 (-3.0A)CHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.72A | 2qd4A-3aqiA:60.7 | 2qd4A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD4_A_CHDA801_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 12 | SER A 195HIS A 263LEU A 265VAL A 269TRP A 310 | NoneCHD A 1 (-4.3A)NoneNoneCHD A 2 (-4.7A) | 1.27A | 2qd4A-3aqiA:60.7 | 2qd4A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD4_A_CHDA802_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 6 | MET A 99ARG A 114PRO A 266VAL A 305MET A 308 | CHD A 2 (-4.0A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)None | 0.66A | 2qd4A-3aqiA:60.7 | 2qd4A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD4_A_CHDA803_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 5 | LEU A 101PRO A 102LEU A 107ILE A 111ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A) | 0.73A | 2qd4A-3aqiA:60.7 | 2qd4A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD4_B_CHDB926_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 9 / 10 | MET A 99LEU A 101ILE A 111ARG A 114PRO A 266SER A 268VAL A 305GLY A 306MET A 308 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)None | 0.52A | 2qd4B-3aqiA:60.6 | 2qd4B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD4_B_CHDB927_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101PRO A 102ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 2 (-3.6A) | 0.44A | 2qd4B-3aqiA:60.6 | 2qd4B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD4_B_CHDB928_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 11 / 12 | LEU A 92PHE A 93LEU A 98MET A 99GLN A 122HIS A 263LEU A 265PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)CHD A 1 ( 4.1A)CHD A 1 (-4.3A)NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.41A | 2qd4B-3aqiA:60.6 | 2qd4B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD5_A_CHDA701_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 8 | MET A 99LEU A 101PRO A 266SER A 268VAL A 305GLY A 306 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A) | 0.74A | 2qd5A-3aqiA:53.6 | 2qd5A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD5_A_CHDA702_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101PRO A 102ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 2 (-3.6A) | 0.52A | 2qd5A-3aqiA:53.6 | 2qd5A-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD5_B_CHDB1103_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 7 / 8 | MET A 99LEU A 101ARG A 114PRO A 266SER A 268VAL A 305GLY A 306 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A) | 0.80A | 2qd5B-3aqiA:53.6 | 2qd5B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QD5_B_CHDB1104_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101PRO A 102LEU A 107 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A) | 0.47A | 2qd5B-3aqiA:53.6 | 2qd5B-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QO4_A_CHDA130_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 7 / 12 | LEU A 23ILE A 21ALA A 31VAL A 34THR A 72MET A 73PHE A 96 | CHD A 130 ( 4.6A)GOL A 145 ( 4.8A)CHD A 130 ( 3.8A)CHD A 130 ( 4.8A)GOL A 145 (-3.2A)NoneCHD A 130 ( 4.6A) | 1.41A | 2qo4A-2qo4A:27.7 | 2qo4A-2qo4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QO4_A_CHDA130_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 12 / 12 | TYR A 14LEU A 18ILE A 21ALA A 31VAL A 34THR A 72MET A 73ASP A 74PHE A 96HIS A 98MET A 118ARG A 120 | NoneCHD A 130 ( 4.7A)GOL A 145 ( 4.8A)CHD A 130 ( 3.8A)CHD A 130 ( 4.8A)GOL A 145 (-3.2A)NoneGOL A 145 ( 2.8A)CHD A 130 ( 4.6A)IPA A 140 (-3.7A)CHD A 130 ( 3.8A)CHD A 130 (-3.4A) | 0.00A | 2qo4A-2qo4A:27.7 | 2qo4A-2qo4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QO5_A_CHDA130_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 5 / 9 | LYS A 56MET A 73LEU A 111MET A 118ARG A 120 | CHD A 130 (-2.9A)NoneCHD A 130 ( 4.9A)CHD A 130 ( 3.8A)CHD A 130 (-3.4A) | 0.94A | 2qo5A-2qo4A:22.3 | 2qo5A-2qo4A:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QO5_A_CHDA130_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 6 / 9 | TYR A 14ALA A 31LYS A 56LEU A 111MET A 118ARG A 120 | NoneCHD A 130 ( 3.8A)CHD A 130 (-2.9A)CHD A 130 ( 4.9A)CHD A 130 ( 3.8A)CHD A 130 (-3.4A) | 0.67A | 2qo5A-2qo4A:22.3 | 2qo5A-2qo4A:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QO5_A_CHDA130_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 7 / 9 | TYR A 14LEU A 18VAL A 27ALA A 31LEU A 111MET A 118ARG A 120 | NoneCHD A 130 ( 4.7A)NoneCHD A 130 ( 3.8A)CHD A 130 ( 4.9A)CHD A 130 ( 3.8A)CHD A 130 (-3.4A) | 0.51A | 2qo5A-2qo4A:22.3 | 2qo5A-2qo4A:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QO5_A_CHDA131_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 6 / 12 | ILE A 21ILE A 49ILE A 70THR A 72VAL A 82LEU A 111 | GOL A 145 ( 4.8A)IPA A 141 (-3.9A)IPA A 141 ( 4.5A)GOL A 145 (-3.2A)NoneCHD A 130 ( 4.9A) | 0.81A | 2qo5A-2qo4A:22.3 | 2qo5A-2qo4A:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QO5_A_CHDA131_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 6 / 12 | ILE A 21ILE A 49THR A 72VAL A 82HIS A 98LEU A 111 | GOL A 145 ( 4.8A)IPA A 141 (-3.9A)GOL A 145 (-3.2A)NoneIPA A 140 (-3.7A)CHD A 130 ( 4.9A) | 0.97A | 2qo5A-2qo4A:22.3 | 2qo5A-2qo4A:98.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QO6_A_CHDA130_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
2qo4 | LIVER-BASIC FATTYACID BINDING PROTEIN (Daniorerio) | 12 / 12 | TYR A 14LEU A 18ILE A 21LEU A 23ALA A 31VAL A 34THR A 72ASP A 74PHE A 96HIS A 98MET A 118ARG A 120 | NoneCHD A 130 ( 4.7A)GOL A 145 ( 4.8A)CHD A 130 ( 4.6A)CHD A 130 ( 3.8A)CHD A 130 ( 4.8A)GOL A 145 (-3.2A)GOL A 145 ( 2.8A)CHD A 130 ( 4.6A)IPA A 140 (-3.7A)CHD A 130 ( 3.8A)CHD A 130 (-3.4A) | 0.08A | 2qo6A-2qo4A:27.1 | 2qo6A-2qo4A:99.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y69_C_CHDC1265_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.12A | 2y69C-5iy5C:37.42y69J-5iy5C:undetectable | 2y69C-5iy5C:100.002y69J-5iy5C:15.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y69_P_CHDP1265_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.16A | 2y69P-5iy5C:37.32y69W-5iy5C:undetectable | 2y69P-5iy5C:100.002y69W-5iy5C:15.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZXW_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156LEU C 160GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.34A | 2zxwP-5iy5C:37.22zxwW-5iy5C:undetectable | 2zxwP-5iy5C:100.002zxwW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ABK_C_CHDC271_0 (CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 4 | ARG C 156GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.54A | 3abkC-5iy5C:37.4 | 3abkC-5iy5C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ABK_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.20A | 3abkP-5iy5C:37.33abkW-5iy5C:undetectable | 3abkP-5iy5C:100.003abkW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ABL_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.25A | 3ablC-5iy5C:37.33ablJ-5iy5C:undetectable | 3ablC-5iy5C:100.003ablJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ABL_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.33A | 3ablP-5iy5C:37.33ablW-5iy5C:undetectable | 3ablP-5iy5C:100.003ablW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ABM_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.19A | 3abmC-5iy5C:37.33abmJ-5iy5C:undetectable | 3abmC-5iy5C:100.003abmJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ABM_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.28A | 3abmP-5iy5C:37.23abmW-5iy5C:undetectable | 3abmP-5iy5C:100.003abmW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG1_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156LEU C 160GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.25A | 3ag1C-5iy5C:36.53ag1J-5iy5C:undetectable | 3ag1C-5iy5C:100.003ag1J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG2_C_CHDC271_0 (CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223PHE C 225 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNoneNone | 0.16A | 3ag2C-5iy5C:37.3 | 3ag2C-5iy5C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG2_C_CHDC271_0 (CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223PHE C 225 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNoneNone | 0.48A | 3ag2C-5iy5C:37.3 | 3ag2C-5iy5C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG2_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.13A | 3ag2P-5iy5C:37.43ag2W-5iy5C:undetectable | 3ag2P-5iy5C:100.003ag2W-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG2_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.51A | 3ag2P-5iy5C:37.43ag2W-5iy5C:undetectable | 3ag2P-5iy5C:100.003ag2W-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG3_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.10A | 3ag3C-5iy5C:37.43ag3J-5iy5C:undetectable | 3ag3C-5iy5C:100.003ag3J-5iy5C:10.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG4_B_CHDB1085_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 2CYTOCHROME C OXIDASESUBUNIT 6A2) |
2y69 | CYTOCHROME C OXIDASEPOLYPEPTIDE 6A2 (Bostaurus) | 5 / 12 | ARG G 14ARG G 17PHE G 18PHE G 21GLY G 22 | CHD G1085 (-3.9A)CHD G1085 (-4.4A)CHD G1085 ( 4.3A)NoneCHD G1085 (-3.5A) | 0.00A | 3ag4A-2y69G:undetectable3ag4B-2y69G:undetectable3ag4T-2y69G:9.8 | 3ag4A-2y69G:11.223ag4B-2y69G:20.353ag4T-2y69G:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG4_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 7 / 8 | ARG C 156LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223PHE C 225 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNoneNone | 0.38A | 3ag4C-5iy5C:37.33ag4J-5iy5C:undetectable | 3ag4C-5iy5C:100.003ag4J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG4_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.00A | 3ag4P-5iy5C:37.33ag4W-5iy5C:undetectable | 3ag4P-5iy5C:100.003ag4W-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AG4_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.45A | 3ag4P-5iy5C:37.33ag4W-5iy5C:undetectable | 3ag4P-5iy5C:100.003ag4W-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AQI_A_CHDA1_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 11 | ILE A 342PRO A 266VAL A 269VAL A 305TRP A 310 | NoneCHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 1.17A | 3aqiA-3aqiA:63.2 | 3aqiA-3aqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AQI_A_CHDA1_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 11 / 11 | MET A 76LEU A 92PHE A 93MET A 99ILE A 119SER A 197HIS A 263PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 2 (-4.0A)NoneCHD A 1 (-3.0A)CHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.49A | 3aqiA-3aqiA:63.2 | 3aqiA-3aqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AQI_A_CHDA2_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 6 | MET A 99ARG A 114PRO A 266GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.00A | 3aqiA-3aqiA:63.2 | 3aqiA-3aqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AQI_A_CHDA3_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | PRO A 102LEU A 107ARG A 114 | CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.00A | 3aqiA-3aqiA:63.2 | 3aqiA-3aqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AQI_B_CHDB4_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 6 | MET A 99ARG A 114PRO A 266GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.40A | 3aqiB-3aqiA:61.5 | 3aqiB-3aqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AQI_B_CHDB5_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | PRO A 102LEU A 107ARG A 114 | CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.51A | 3aqiB-3aqiA:61.5 | 3aqiB-3aqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AQI_B_CHDB6_0 (FERROCHELATASE) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99ILE A 119SER A 197HIS A 263PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneCHD A 1 (-3.0A)CHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.30A | 3aqiB-3aqiA:61.5 | 3aqiB-3aqiA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ASN_C_CHDC271_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 7 | ARG C 156LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.40A | 3asnC-5iy5C:37.43asnJ-5iy5C:undetectable | 3asnC-5iy5C:100.003asnJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ASN_P_CHDP1271_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.34A | 3asnP-5iy5C:37.43asnW-5iy5C:undetectable | 3asnP-5iy5C:100.003asnW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ASO_P_CHDP1271_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.33A | 3asoP-5iy5C:37.43asoW-5iy5C:undetectable | 3asoP-5iy5C:100.003asoW-5iy5C:10.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EKP_B_478B200_1 (PROTEASE) |
1ee2 | ALCOHOLDEHYDROGENASE (Equuscaballus) | 5 / 8 | LEU A 110GLY A 315ALA A 316GLY A 292ILE A 317 | NoneNoneNoneNAD A1100 (-3.5A)CHD A1150 ( 4.3A) | 1.22A | 3ekpA-1ee2A:0.0 | 3ekpA-1ee2A:12.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_A_CHDA150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 12 / 12 | TRP A 49GLN A 51ASN A 61PHE A 63MET A 71THR A 73VAL A 74VAL A 83LEU A 90ILE A 92TYR A 97THR A 101 | CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 150 ( 4.0A)CHD A 150 (-4.1A)CHD A 150 ( 3.7A)CHD A 200 (-3.1A)CHD A 200 (-3.7A)CHD A 150 (-4.4A)CHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 153 (-4.2A)CHD A 150 (-2.9A) | 0.00A | 3elzA-3elzA:27.5 | 3elzA-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_A_CHDA151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 7 | ILE A 21TYR A 53VAL A 74LEU A 123ARG A 125 | CHD A 153 ( 4.1A)CHD A 151 (-4.5A)CHD A 200 (-3.7A)CHD A 151 (-4.2A)CHD A 151 (-4.1A) | 1.41A | 3elzA-3elzA:27.5 | 3elzA-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_A_CHDA151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 7 / 7 | TYR A 14ILE A 23GLY A 31TYR A 53VAL A 74LEU A 123ARG A 125 | CHD A 151 (-4.9A)CHD A 200 ( 4.7A)CHD A 151 (-3.6A)CHD A 151 (-4.5A)CHD A 200 (-3.7A)CHD A 151 (-4.2A)CHD A 151 (-4.1A) | 0.00A | 3elzA-3elzA:27.5 | 3elzA-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_A_CHDA152_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 3 / 3 | VAL A 27LYS A 30HIS A 57 | CHD A 152 ( 4.3A)CHD A 152 ( 4.1A)CHD A 152 (-3.7A) | 0.00A | 3elzA-3elzA:27.5 | 3elzA-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_A_CHDA153_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 4 / 4 | ILE A 21THR A 73LYS A 77TYR A 97 | CHD A 153 ( 4.1A)CHD A 200 (-3.1A)CHD A 153 ( 4.6A)CHD A 153 (-4.2A) | 0.00A | 3elzA-3elzA:27.5 | 3elzA-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_A_CHDA200_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 5 | PRO A 24THR A 73VAL A 74GLY A 75LYS A 77 | CHD A 200 (-4.7A)CHD A 200 (-3.1A)CHD A 200 (-3.7A)CHD A 200 (-3.4A)CHD A 153 ( 4.6A) | 0.01A | 3elzA-3elzA:27.5 | 3elzA-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_B_CHDB150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 11 / 11 | TRP A 49GLN A 51MET A 71THR A 73VAL A 74VAL A 83LEU A 90ILE A 92TYR A 97GLN A 99THR A 101 | CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 150 ( 3.7A)CHD A 200 (-3.1A)CHD A 200 (-3.7A)CHD A 150 (-4.4A)CHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 153 (-4.2A)CHD A 150 (-3.3A)CHD A 150 (-2.9A) | 0.41A | 3elzB-3elzA:24.8 | 3elzB-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_B_CHDB151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 10 / 10 | TYR A 14ILE A 21ILE A 23GLY A 31PHE A 34TYR A 53PRO A 54VAL A 74LEU A 123ARG A 125 | CHD A 151 (-4.9A)CHD A 153 ( 4.1A)CHD A 200 ( 4.7A)CHD A 151 (-3.6A)CHD A 151 ( 4.6A)CHD A 151 (-4.5A)NoneCHD A 200 (-3.7A)CHD A 151 (-4.2A)CHD A 151 (-4.1A) | 0.53A | 3elzB-3elzA:24.8 | 3elzB-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_B_CHDB152_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 3 / 3 | ASN A 55HIS A 57VAL A 74 | NoneCHD A 152 (-3.7A)CHD A 200 (-3.7A) | 0.42A | 3elzB-3elzA:24.8 | 3elzB-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_B_CHDB153_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 6 | ILE A 21THR A 73PHE A 79PHE A 94TYR A 97 | CHD A 153 ( 4.1A)CHD A 200 (-3.1A)CHD A 153 ( 4.9A)NoneCHD A 153 (-4.2A) | 0.52A | 3elzB-3elzA:24.8 | 3elzB-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_B_CHDB200_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 5 | PRO A 24VAL A 27THR A 73GLY A 75LYS A 77 | CHD A 200 (-4.7A)CHD A 152 ( 4.3A)CHD A 200 (-3.1A)CHD A 200 (-3.4A)CHD A 153 ( 4.6A) | 1.08A | 3elzB-3elzA:24.8 | 3elzB-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_C_CHDC150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 11 / 12 | TRP A 49GLN A 51ASN A 61THR A 73PHE A 79VAL A 83LEU A 90ILE A 92TYR A 97GLN A 99THR A 101 | CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 150 ( 4.0A)CHD A 200 (-3.1A)CHD A 153 ( 4.9A)CHD A 150 (-4.4A)CHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 153 (-4.2A)CHD A 150 (-3.3A)CHD A 150 (-2.9A) | 0.54A | 3elzC-3elzA:24.4 | 3elzC-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_C_CHDC150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 11 / 12 | TRP A 49GLN A 51ASN A 61THR A 73VAL A 74VAL A 83LEU A 90ILE A 92TYR A 97GLN A 99THR A 101 | CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 150 ( 4.0A)CHD A 200 (-3.1A)CHD A 200 (-3.7A)CHD A 150 (-4.4A)CHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 153 (-4.2A)CHD A 150 (-3.3A)CHD A 150 (-2.9A) | 0.53A | 3elzC-3elzA:24.4 | 3elzC-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_C_CHDC150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 12 | VAL A 59VAL A 83ILE A 92GLN A 99THR A 101 | NoneCHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 150 (-3.3A)CHD A 150 (-2.9A) | 1.11A | 3elzC-3elzA:24.4 | 3elzC-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_C_CHDC151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 10 | ILE A 23TYR A 53VAL A 74LEU A 123ARG A 125 | CHD A 200 ( 4.7A)CHD A 151 (-4.5A)CHD A 200 (-3.7A)CHD A 151 (-4.2A)CHD A 151 (-4.1A) | 1.18A | 3elzC-3elzA:21.6 | 3elzC-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_C_CHDC151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 10 / 10 | TYR A 14ILE A 21ILE A 23VAL A 27GLY A 31TYR A 53PRO A 54VAL A 74LEU A 123ARG A 125 | CHD A 151 (-4.9A)CHD A 153 ( 4.1A)CHD A 200 ( 4.7A)CHD A 152 ( 4.3A)CHD A 151 (-3.6A)CHD A 151 (-4.5A)NoneCHD A 200 (-3.7A)CHD A 151 (-4.2A)CHD A 151 (-4.1A) | 0.54A | 3elzC-3elzA:21.6 | 3elzC-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELZ_C_CHDC153_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 4 / 4 | ILE A 21THR A 73LYS A 77TYR A 97 | CHD A 153 ( 4.1A)CHD A 200 (-3.1A)CHD A 153 ( 4.6A)CHD A 153 (-4.2A) | 0.93A | 3elzC-3elzA:24.4 | 3elzC-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_A_CHDA150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 12 / 12 | TRP A 49GLN A 51ASN A 61MET A 71THR A 73VAL A 74PHE A 79VAL A 83ILE A 92TYR A 97GLN A 99THR A 101 | CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 150 ( 4.0A)CHD A 150 ( 3.7A)CHD A 200 (-3.1A)CHD A 200 (-3.7A)CHD A 153 ( 4.9A)CHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 153 (-4.2A)CHD A 150 (-3.3A)CHD A 150 (-2.9A) | 0.65A | 3em0A-3elzA:24.6 | 3em0A-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_A_CHDA150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 12 | VAL A 59VAL A 83ILE A 92GLN A 99THR A 101 | NoneCHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 150 (-3.3A)CHD A 150 (-2.9A) | 1.01A | 3em0A-3elzA:24.6 | 3em0A-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_A_CHDA151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 7 / 10 | TYR A 14CYH A 18ILE A 21ILE A 23LYS A 30GLY A 31LEU A 123 | CHD A 151 (-4.9A)CHD A 151 ( 4.2A)CHD A 153 ( 4.1A)CHD A 200 ( 4.7A)CHD A 152 ( 4.1A)CHD A 151 (-3.6A)CHD A 151 (-4.2A) | 1.05A | 3em0A-3elzA:24.6 | 3em0A-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_A_CHDA151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 9 / 10 | TYR A 14CYH A 18ILE A 21ILE A 23VAL A 27GLY A 31TYR A 53VAL A 74LEU A 123 | CHD A 151 (-4.9A)CHD A 151 ( 4.2A)CHD A 153 ( 4.1A)CHD A 200 ( 4.7A)CHD A 152 ( 4.3A)CHD A 151 (-3.6A)CHD A 151 (-4.5A)CHD A 200 (-3.7A)CHD A 151 (-4.2A) | 0.59A | 3em0A-3elzA:24.6 | 3em0A-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_A_CHDA153_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 4 / 5 | ILE A 21THR A 73PHE A 79TYR A 97 | CHD A 153 ( 4.1A)CHD A 200 (-3.1A)CHD A 153 ( 4.9A)CHD A 153 (-4.2A) | 0.75A | 3em0A-3elzA:24.6 | 3em0A-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_B_CHDB150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 11 / 12 | PHE A 17ILE A 21TRP A 49GLN A 51ASN A 61MET A 71PHE A 79VAL A 83LEU A 90ILE A 92THR A 101 | NoneCHD A 153 ( 4.1A)CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 150 ( 4.0A)CHD A 150 ( 3.7A)CHD A 153 ( 4.9A)CHD A 150 (-4.4A)CHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 150 (-2.9A) | 0.77A | 3em0B-3elzA:23.6 | 3em0B-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_B_CHDB150_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 11 / 12 | PHE A 17TRP A 49GLN A 51ASN A 61MET A 71THR A 73PHE A 79VAL A 83LEU A 90ILE A 92THR A 101 | NoneCHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 150 ( 4.0A)CHD A 150 ( 3.7A)CHD A 200 (-3.1A)CHD A 153 ( 4.9A)CHD A 150 (-4.4A)CHD A 150 (-4.4A)CHD A 150 (-3.9A)CHD A 150 (-2.9A) | 0.65A | 3em0B-3elzA:23.6 | 3em0B-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_B_CHDB151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 9 / 12 | TYR A 14CYH A 18ILE A 21ILE A 23VAL A 27LYS A 30GLY A 31PHE A 34LEU A 123 | CHD A 151 (-4.9A)CHD A 151 ( 4.2A)CHD A 153 ( 4.1A)CHD A 200 ( 4.7A)CHD A 152 ( 4.3A)CHD A 152 ( 4.1A)CHD A 151 (-3.6A)CHD A 151 ( 4.6A)CHD A 151 (-4.2A) | 0.70A | 3em0B-3elzA:23.6 | 3em0B-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_B_CHDB151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 6 / 12 | TYR A 14GLY A 31PHE A 34LEU A 36LEU A 123ARG A 125 | CHD A 151 (-4.9A)CHD A 151 (-3.6A)CHD A 151 ( 4.6A)NoneCHD A 151 (-4.2A)CHD A 151 (-4.1A) | 1.35A | 3em0B-3elzA:23.6 | 3em0B-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_B_CHDB151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 6 / 12 | TYR A 14PHE A 34LEU A 36PRO A 54LEU A 123ARG A 125 | CHD A 151 (-4.9A)CHD A 151 ( 4.6A)NoneNoneCHD A 151 (-4.2A)CHD A 151 (-4.1A) | 1.44A | 3em0B-3elzA:23.6 | 3em0B-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_B_CHDB151_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 7 / 12 | TYR A 14VAL A 27LYS A 30GLY A 31PHE A 34LEU A 123ARG A 125 | CHD A 151 (-4.9A)CHD A 152 ( 4.3A)CHD A 152 ( 4.1A)CHD A 151 (-3.6A)CHD A 151 ( 4.6A)CHD A 151 (-4.2A)CHD A 151 (-4.1A) | 1.15A | 3em0B-3elzA:23.6 | 3em0B-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_B_CHDB152_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 8 | TYR A 53PRO A 54ASN A 55VAL A 74GLY A 75 | CHD A 151 (-4.5A)NoneNoneCHD A 200 (-3.7A)CHD A 200 (-3.4A) | 0.64A | 3em0B-3elzA:23.6 | 3em0B-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EM0_B_CHDB153_0 (ILEAL BILEACID-BINDING PROTEIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 4 / 7 | ILE A 21PHE A 79TYR A 97GLY A 116 | CHD A 153 ( 4.1A)CHD A 153 ( 4.9A)CHD A 153 (-4.2A)None | 0.50A | 3em0B-3elzA:23.6 | 3em0B-3elzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCN_A_CHDA3_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 7 | MET A 99LEU A 101PRO A 266SER A 268GLY A 306 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 2 ( 3.8A) | 0.89A | 3hcnA-3aqiA:54.1 | 3hcnA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCN_B_CHDB1_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 7 / 9 | MET A 99LEU A 101ARG A 114PRO A 266SER A 268VAL A 305GLY A 306 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A) | 1.01A | 3hcnB-3aqiA:54.5 | 3hcnB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCN_B_CHDB1_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 7 / 9 | MET A 99LEU A 101PRO A 266SER A 268VAL A 305GLY A 306MET A 308 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)None | 0.87A | 3hcnB-3aqiA:54.5 | 3hcnB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCN_B_CHDB2_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101LEU A 107ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.65A | 3hcnB-3aqiA:54.5 | 3hcnB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCO_A_CHDA3_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 4 | LEU A 101PRO A 102LEU A 107ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.80A | 3hcoA-3aqiA:54.0 | 3hcoA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCO_A_CHDA4_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 9 | MET A 99LEU A 101PRO A 266SER A 268VAL A 305GLY A 306PRO A 307MET A 308 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneNone | 0.76A | 3hcoA-3aqiA:54.0 | 3hcoA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCO_B_CHDB1_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 4 | LEU A 101PRO A 102LEU A 107ARG A 114 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 (-3.6A) | 0.49A | 3hcoB-3aqiA:54.4 | 3hcoB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCO_B_CHDB924_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 10 | MET A 99LEU A 101ARG A 114PRO A 266SER A 268VAL A 305GLY A 306MET A 308 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)None | 0.90A | 3hcoB-3aqiA:54.4 | 3hcoB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCO_B_CHDB924_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 10 | MET A 99LEU A 101PRO A 266SER A 268VAL A 305GLY A 306PRO A 307MET A 308 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneNone | 0.69A | 3hcoB-3aqiA:54.4 | 3hcoB-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCP_A_CHDA2_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 9 | LEU A 101ARG A 114PRO A 266SER A 268GLY A 306PRO A 307MET A 308TRP A 310 | CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 2 ( 3.8A)NoneNoneCHD A 2 (-4.7A) | 0.89A | 3hcpA-3aqiA:59.9 | 3hcpA-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCP_B_CHDB1_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 9 / 10 | MET A 99LEU A 101ILE A 111ARG A 114PRO A 266SER A 268GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.61A | 3hcpB-3aqiA:60.5 | 3hcpB-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCR_A_CHDA424_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 8 | LEU A 101ARG A 114PRO A 266GLY A 306 | CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 3.8A) | 0.78A | 3hcrA-3aqiA:53.5 | 3hcrA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCR_A_CHDA424_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 8 | LEU A 101PRO A 266GLY A 306PRO A 307 | CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 3.8A)None | 0.62A | 3hcrA-3aqiA:53.5 | 3hcrA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCR_A_CHDA424_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 8 | PRO A 266SER A 268GLY A 306PRO A 307MET A 308 | CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 2 ( 3.8A)NoneNone | 0.25A | 3hcrA-3aqiA:53.5 | 3hcrA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCR_A_CHDA4_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101PRO A 102LEU A 107 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A) | 0.47A | 3hcrA-3aqiA:53.5 | 3hcrA-3aqiA:99.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HCR_B_CHDB924_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 7 | LEU A 101ARG A 114PRO A 266SER A 268GLY A 306MET A 308 | CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 2 ( 3.8A)None | 0.83A | 3hcrB-3aqiA:53.6 | 3hcrB-3aqiA:99.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VW1_D_CVID301_1 (PUTATIVE REGULATORYPROTEIN) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | TYR A 191MET A 99LEU A 92 | NoneCHD A 2 (-4.0A)CHD A 1 (-4.8A) | 0.70A | 3vw1D-3aqiA:undetectable | 3vw1D-3aqiA:19.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W1W_A_CHDA1502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 12 / 12 | MET A 76LEU A 92PHE A 93LEU A 98MET A 99ILE A 119SER A 197HIS A 263PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 2 (-4.0A)NoneCHD A 1 (-3.0A)CHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.43A | 3w1wA-3aqiA:60.5 | 3w1wA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W1W_A_CHDA1503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 8 | MET A 99ILE A 111ARG A 114LEU A 115VAL A 305GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.26A | 3w1wA-3aqiA:60.5 | 3w1wA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W1W_A_CHDA1504_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 4 | PRO A 102LEU A 107ILE A 111ARG A 114 | CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A) | 0.41A | 3w1wA-3aqiA:60.5 | 3w1wA-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W1W_B_CHDB502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 9 / 9 | MET A 99ILE A 111ARG A 114LEU A 115PRO A 266SER A 268GLY A 306MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A)CHD A 2 ( 4.8A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 2 ( 3.8A)NoneCHD A 2 (-4.7A) | 0.33A | 3w1wB-3aqiA:60.3 | 3w1wB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W1W_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 101PRO A 102LEU A 107 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A) | 0.38A | 3w1wB-3aqiA:60.3 | 3w1wB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W1W_B_CHDB504_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 11 / 12 | MET A 76LEU A 92PHE A 93LEU A 98ILE A 119GLN A 122HIS A 263PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)NoneCHD A 1 ( 4.1A)CHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.41A | 3w1wB-3aqiA:60.3 | 3w1wB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W1W_B_CHDB504_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 12 | MET A 76LEU A 98HIS A 263PRO A 266VAL A 269VAL A 305TRP A 310GLU A 343 | CHD A 1 ( 3.8A)CHD A 1 (-4.3A)CHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A)None | 0.96A | 3w1wB-3aqiA:60.3 | 3w1wB-3aqiA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3WG7_C_CHDC305_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.06A | 3wg7C-5iy5C:37.23wg7J-5iy5C:undetectable | 3wg7C-5iy5C:100.003wg7J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3X2Q_C_CHDC304_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.06A | 3x2qC-5iy5C:37.43x2qJ-5iy5C:undetectable | 3x2qC-5iy5C:100.003x2qJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3X2Q_C_CHDC304_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.56A | 3x2qC-5iy5C:37.43x2qJ-5iy5C:undetectable | 3x2qC-5iy5C:100.003x2qJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3X2Q_P_CHDP307_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.19A | 3x2qP-5iy5C:37.43x2qW-5iy5C:undetectable | 3x2qP-5iy5C:100.003x2qW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3X2Q_P_CHDP307_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.54A | 3x2qP-5iy5C:37.43x2qW-5iy5C:undetectable | 3x2qP-5iy5C:100.003x2qW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4F4D_A_CHDA504_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 12 | LEU A 89LEU A 92LEU A 98ILE A 119GLN A 122THR A 198HIS A 263VAL A 305 | NoneCHD A 1 (-4.8A)CHD A 1 (-4.3A)NoneCHD A 1 ( 4.1A)NoneCHD A 1 (-4.3A)CHD A 1 ( 4.9A) | 0.60A | 4f4dA-3aqiA:60.3 | 4f4dA-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4F4D_A_CHDA505_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 7 | MET A 99ILE A 111VAL A 305MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.7A)CHD A 1 ( 4.9A)NoneCHD A 2 (-4.7A) | 0.32A | 4f4dA-3aqiA:60.3 | 4f4dA-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4F4D_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 8 | MET A 99ILE A 111PRO A 266VAL A 305MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.7A)CHD A 2 ( 4.5A)CHD A 1 ( 4.9A)NoneCHD A 2 (-4.7A) | 0.21A | 4f4dB-3aqiA:60.7 | 4f4dB-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4F4D_B_CHDB504_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 4 | LEU A 101PRO A 102LEU A 107ILE A 111 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 ( 4.7A) | 0.34A | 4f4dB-3aqiA:60.7 | 4f4dB-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4F4D_B_CHDB505_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 9 / 12 | LEU A 89LEU A 92LEU A 98ILE A 119SER A 197THR A 198HIS A 263VAL A 305TRP A 310 | NoneCHD A 1 (-4.8A)CHD A 1 (-4.3A)NoneCHD A 1 (-3.0A)NoneCHD A 1 (-4.3A)CHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.45A | 4f4dB-3aqiA:60.7 | 4f4dB-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4F4D_B_CHDB505_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 12 | LEU A 89LEU A 92LEU A 98LYS A 118ILE A 119SER A 197VAL A 305TRP A 310 | NoneCHD A 1 (-4.8A)CHD A 1 (-4.3A)NoneNoneCHD A 1 (-3.0A)CHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.93A | 4f4dB-3aqiA:60.7 | 4f4dB-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KLA_A_CHDA501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 7 | MET A 99LYS A 118SER A 268MET A 308 | CHD A 2 (-4.0A)NoneCHD A 2 ( 4.4A)None | 1.16A | 4klaA-3aqiA:59.2 | 4klaA-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KLA_A_CHDA501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 7 | MET A 99SER A 268VAL A 305MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)NoneCHD A 2 (-4.7A) | 0.29A | 4klaA-3aqiA:59.2 | 4klaA-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KLA_B_CHDB501_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 5 | MET A 99ARG A 114PRO A 266MET A 308 | CHD A 2 (-4.0A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)None | 0.57A | 4klaB-3aqiA:59.2 | 4klaB-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KLR_A_CHDA504_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 7 | LEU A 101ARG A 114PRO A 266SER A 268VAL A 305MET A 308 | CHD A 3 ( 4.9A)CHD A 2 (-3.6A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)None | 0.91A | 4klrA-3aqiA:53.6 | 4klrA-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KLR_A_CHDA505_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 5 | LEU A 101PRO A 102LEU A 107ILE A 111 | CHD A 3 ( 4.9A)CHD A 3 ( 4.7A)CHD A 3 ( 4.6A)CHD A 2 ( 4.7A) | 0.52A | 4klrA-3aqiA:53.6 | 4klrA-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KLR_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 8 | LEU A 101PRO A 266SER A 268GLY A 306 | CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 2 ( 3.8A) | 0.73A | 4klrB-3aqiA:52.9 | 4klrB-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KMM_A_CHDA503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 6 / 7 | MET A 99PRO A 266SER A 268VAL A 305MET A 308TRP A 310 | CHD A 2 (-4.0A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)CHD A 1 ( 4.9A)NoneCHD A 2 (-4.7A) | 0.29A | 4kmmA-3aqiA:59.7 | 4kmmA-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KMM_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 4 / 5 | MET A 99LEU A 101PRO A 266SER A 268 | CHD A 2 (-4.0A)CHD A 3 ( 4.9A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A) | 0.46A | 4kmmB-3aqiA:59.5 | 4kmmB-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MK4_A_CHDA503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 8 / 10 | LEU A 89LEU A 92LEU A 98ILE A 119THR A 198HIS A 263VAL A 305TRP A 310 | NoneCHD A 1 (-4.8A)CHD A 1 (-4.3A)NoneNoneCHD A 1 (-4.3A)CHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.54A | 4mk4A-3aqiA:59.3 | 4mk4A-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MK4_A_CHDA503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 7 / 10 | LEU A 89LEU A 92LEU A 98LYS A 118ILE A 119VAL A 305TRP A 310 | NoneCHD A 1 (-4.8A)CHD A 1 (-4.3A)NoneNoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 1.10A | 4mk4A-3aqiA:59.3 | 4mk4A-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MK4_A_CHDA504_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 7 / 8 | MET A 99PRO A 266SER A 268VAL A 269ARG A 272VAL A 305GLY A 306 | CHD A 2 (-4.0A)CHD A 2 ( 4.5A)CHD A 2 ( 4.4A)NoneFES A 501 (-4.1A)CHD A 1 ( 4.9A)CHD A 2 ( 3.8A) | 0.33A | 4mk4A-3aqiA:59.3 | 4mk4A-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MK4_B_CHDB502_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 5 / 6 | PHE A 93MET A 99ILE A 111ARG A 114VAL A 305 | CHD A 1 ( 4.7A)CHD A 2 (-4.0A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A)CHD A 1 ( 4.9A) | 0.59A | 4mk4B-3aqiA:59.3 | 4mk4B-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MK4_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 9 / 11 | MET A 76LEU A 92PHE A 93LEU A 98HIS A 263PRO A 266VAL A 269VAL A 305TRP A 310 | CHD A 1 ( 3.8A)CHD A 1 (-4.8A)CHD A 1 ( 4.7A)CHD A 1 (-4.3A)CHD A 1 (-4.3A)CHD A 2 ( 4.5A)NoneCHD A 1 ( 4.9A)CHD A 2 (-4.7A) | 0.27A | 4mk4B-3aqiA:59.3 | 4mk4B-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MK4_B_CHDB504_0 (FERROCHELATASE,MITOCHONDRIAL) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | LEU A 107ILE A 111ARG A 114 | CHD A 3 ( 4.6A)CHD A 2 ( 4.7A)CHD A 2 (-3.6A) | 0.65A | 4mk4B-3aqiA:59.3 | 4mk4B-3aqiA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B1B_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.14A | 5b1bC-5iy5C:37.45b1bJ-5iy5C:undetectable | 5b1bC-5iy5C:100.005b1bJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B1B_P_CHDP306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.00A | 5b1bP-5iy5C:37.35b1bW-5iy5C:undetectable | 5b1bP-5iy5C:100.005b1bW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B1B_P_CHDP306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.45A | 5b1bP-5iy5C:37.35b1bW-5iy5C:undetectable | 5b1bP-5iy5C:100.005b1bW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IY5_P_CHDP307_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.07A | 5iy5P-5iy5C:37.55iy5W-5iy5C:undetectable | 5iy5P-5iy5C:100.005iy5W-5iy5C:10.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L8O_B_CHDB1001_0 (GASTROTROPIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 12 | TRP A 49GLN A 51LEU A 90GLU A 110SER A 112 | CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 150 (-4.4A)NoneNone | 0.57A | 5l8oB-3elzA:20.4 | 5l8oB-3elzA:55.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L8O_B_CHDB1001_0 (GASTROTROPIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 12 | TRP A 49GLN A 51THR A 73LEU A 90SER A 112 | CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 200 (-3.1A)CHD A 150 (-4.4A)None | 0.82A | 5l8oB-3elzA:20.4 | 5l8oB-3elzA:55.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L8O_B_CHDB1001_0 (GASTROTROPIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 12 | TRP A 49GLN A 51THR A 73PHE A 79LEU A 90 | CHD A 150 (-3.5A)CHD A 150 ( 3.7A)CHD A 200 (-3.1A)CHD A 153 ( 4.9A)CHD A 150 (-4.4A) | 0.91A | 5l8oB-3elzA:20.4 | 5l8oB-3elzA:55.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L8O_B_CHDB1001_0 (GASTROTROPIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 12 | TRP A 49LEU A 90GLN A 99GLU A 110SER A 112 | CHD A 150 (-3.5A)CHD A 150 (-4.4A)CHD A 150 (-3.3A)NoneNone | 0.90A | 5l8oB-3elzA:20.4 | 5l8oB-3elzA:55.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L8O_B_CHDB1001_0 (GASTROTROPIN) |
3elz | ILEAL BILEACID-BINDING PROTEIN (Daniorerio) | 5 / 12 | TRP A 49THR A 73LEU A 90GLN A 99SER A 112 | CHD A 150 (-3.5A)CHD A 200 (-3.1A)CHD A 150 (-4.4A)CHD A 150 (-3.3A)None | 0.98A | 5l8oB-3elzA:20.4 | 5l8oB-3elzA:55.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5W97_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156LYS C 157LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.23A | 5w97C-5iy5C:36.65w97J-5iy5C:undetectable | 5w97C-5iy5C:100.005w97J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WAU_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.11A | 5wauC-5iy5C:37.45wauJ-5iy5C:undetectable | 5wauC-5iy5C:100.005wauJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WAU_C_CHDC308_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.12A | 5wauc-5iy5C:37.45wauj-5iy5C:undetectable | 5wauc-5iy5C:100.005wauj-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X19_C_CHDC304_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156LEU C 160PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)NoneNone | 0.08A | 5x19C-5iy5C:36.55x19J-5iy5C:undetectable | 5x19C-5iy5C:100.005x19J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X19_P_CHDP305_0 (CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 6 | ARG C 156LYS C 157LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.33A | 5x19P-5iy5C:36.5 | 5x19P-5iy5C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X1B_C_CHDC304_0 (CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 3 / 3 | ARG C 156PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)None | 0.00A | 5x1bC-5iy5C:35.8 | 5x1bC-5iy5C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X1B_P_CHDP305_0 (CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 5 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.14A | 5x1bP-5iy5C:35.6 | 5x1bP-5iy5C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X1F_C_CHDC304_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.22A | 5x1fC-5iy5C:36.75x1fJ-5iy5C:undetectable | 5x1fC-5iy5C:100.005x1fJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X1F_P_CHDP304_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 6 / 7 | ARG C 156LYS C 157LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.21A | 5x1fP-5iy5C:36.65x1fW-5iy5C:undetectable | 5x1fP-5iy5C:100.005x1fW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XDQ_C_CHDC308_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.12A | 5xdqC-5iy5C:37.65xdqJ-5iy5C:undetectable | 5xdqC-5iy5C:100.005xdqJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XDQ_P_CHDP306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.00A | 5xdqP-5iy5C:37.55xdqW-5iy5C:undetectable | 5xdqP-5iy5C:100.005xdqW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XDX_C_CHDC308_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT VIIA-HEART) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.00A | 5xdxC-5iy5C:37.55xdxJ-5iy5C:undetectable | 5xdxC-5iy5C:100.005xdxJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XDX_P_CHDP306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT VIIA-HEART) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156LEU C 160PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)None | 0.15A | 5xdxP-5iy5C:37.55xdxW-5iy5C:undetectable | 5xdxP-5iy5C:100.005xdxW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z84_P_CHDP305_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.69A | 5z84P-5iy5C:37.55z84W-5iy5C:undetectable | 5z84P-5iy5C:100.005z84W-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z85_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.13A | 5z85C-5iy5C:37.55z85J-5iy5C:undetectable | 5z85C-5iy5C:100.005z85J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z85_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.59A | 5z85C-5iy5C:37.55z85J-5iy5C:undetectable | 5z85C-5iy5C:100.005z85J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z85_P_CHDP307_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.69A | 5z85P-5iy5C:37.55z85W-5iy5C:undetectable | 5z85P-5iy5C:100.005z85W-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z86_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.63A | 5z86C-5iy5C:37.55z86J-5iy5C:undetectable | 5z86C-5iy5C:100.005z86J-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z86_P_CHDP307_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.68A | 5z86P-5iy5C:37.55z86W-5iy5C:undetectable | 5z86P-5iy5C:100.005z86W-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCO_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.07A | 5zcoC-5iy5C:37.55zcoJ-5iy5C:undetectable | 5zcoC-5iy5C:100.005zcoJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCO_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.57A | 5zcoC-5iy5C:37.55zcoJ-5iy5C:undetectable | 5zcoC-5iy5C:100.005zcoJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCO_P_CHDP305_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 6 | ARG C 156PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-3.9A)NoneNone | 0.16A | 5zcoP-5iy5C:37.55zcoW-5iy5C:undetectable | 5zcoP-5iy5C:100.005zcoW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCO_P_CHDP305_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 6 | GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.61A | 5zcoP-5iy5C:37.55zcoW-5iy5C:undetectable | 5zcoP-5iy5C:100.005zcoW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCP_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.69A | 5zcpC-5iy5C:37.55zcpJ-5iy5C:undetectable | 5zcpC-5iy5C:100.005zcpJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCP_P_CHDP306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.70A | 5zcpP-5iy5C:37.45zcpW-5iy5C:undetectable | 5zcpP-5iy5C:100.005zcpW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCQ_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.13A | 5zcqC-5iy5C:37.55zcqJ-5iy5C:undetectable | 5zcqC-5iy5C:100.005zcqJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCQ_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.56A | 5zcqC-5iy5C:37.55zcqJ-5iy5C:undetectable | 5zcqC-5iy5C:100.005zcqJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCQ_P_CHDP306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | ARG C 156LEU C 160PHE C 164PHE C 219LEU C 223 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A)NoneNone | 0.16A | 5zcqP-5iy5C:37.45zcqW-5iy5C:undetectable | 5zcqP-5iy5C:100.005zcqW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZCQ_P_CHDP306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 7 | LEU C 160GLN C 161PHE C 164PHE C 219LEU C 223 | CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)NoneNone | 0.60A | 5zcqP-5iy5C:37.45zcqW-5iy5C:undetectable | 5zcqP-5iy5C:100.005zcqW-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6NKN_W_CHDW101_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 3 / 3 | ARG C 156LEU C 160PHE C 164 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-3.9A) | 0.15A | 6nknP-5iy5C:35.8 | 6nknP-5iy5C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6NMF_C_CHDC305_0 (CYTOCHROME C OXIDASESUBUNIT 3) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 4 | ARG C 156GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)CHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.27A | 6nmfC-5iy5C:35.8 | 6nmfC-5iy5C:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6NMP_C_CHDC307_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 5 / 6 | ARG C 156LYS C 157GLN C 161PHE C 164LEU C 223 | CHD C 307 (-4.0A)NoneCHD C 307 (-4.3A)CHD C 307 (-3.9A)None | 0.59A | 6nmpC-5iy5C:35.86nmpJ-5iy5C:undetectable | 6nmpC-5iy5C:100.006nmpJ-5iy5C:10.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6NMP_P_CHDP307_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
5iy5 | CYTOCHROME C OXIDASESUBUNIT 3 (Bostaurus) | 4 / 5 | ARG C 156LEU C 160GLN C 161PHE C 164 | CHD C 307 (-4.0A)CHD C 307 ( 3.9A)CHD C 307 (-4.3A)CHD C 307 (-3.9A) | 0.53A | 6nmpP-5iy5C:35.76nmpW-5iy5C:undetectable | 6nmpP-5iy5C:100.006nmpW-5iy5C:10.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 7DFR_A_FOLA161_1 (DIHYDROFOLATEREDUCTASE) |
3aqi | FERROCHELATASE (Homosapiens) | 3 / 3 | ASP A 95LEU A 98ARG A 272 | NoneCHD A 1 (-4.3A)FES A 501 (-4.1A) | 0.83A | 7dfrA-3aqiA:undetectable | 7dfrA-3aqiA:18.05 |